Rat IL-2 Matched Antibody Pairs

Description: Each Module Set is sufficient for ten 96-well microtiter plates and are identical to eBioscience high quality ready-to-use Conventional ELISAs

IL-2 plays a central role in the activation and proliferation of lymphocytes that have been primed by antigens. IL-2 plays a pivotal role in for the expansion of most T-cells, natural killer cells and B-cells during certain phases of their response. IL-2 is a 15 kDa glycoprotein encoded by a single gene located in the q26-28 region of human chromosome 4. The cDNA deduced polypeptide consists of 153 amino acids. Apart from its most important role to mediate antigen-specific T-lymphocyte proliferation, IL-2 modulates the expression of interferon gamma and major histocompatibility antigens, stimulates proliferation and differentiation of activated B-cells, augments natural killer cell activity and inhibits granulocyte-macrophage colony formation. IL-2 displays antitumoral effects, thus being used in cancer therapy. Monitoring of IL-2 levels in serum provides more detailed insights in several pathological situations such as cancer, infectious diseases, transplant rejection, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus and type I diabetes.

References: Naldini,A.; Fleischmann,W.R.,Jr.; Ballas,Z.K.; Klimpel,K.D.; Klimpel,G.R.. Interleukin 2 inhibits in vitro granulocyte-macrophage colony formation. J.Immunol. 1987;139:1880-1884. (Link)

Tigges,M.A.; Casey,L.S.; Koshland,M.E.. Mechanism of interleukin-2 signaling: mediation of different outcomes by a single receptor and transduction pathway. Science 1989;243:781-786. (Link)

Gressler,V.H.; Weinkauff,R.E.; Franklin,W.A.; Golomb,H.M.. Modulation of the expression of major histocompatibility antigens on splenic hairy cells--differential effect upon in vitro treatment with alpha-2b-interferon, gamma-interferon, and interleukin-2. Blood 1988;72:1048-1053. (Link)

Phadke,K.; Carlson,D.G.; Gitter,B.D.; Butler,L.D.. Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models. J.Immunol. 1986;136:4085-4091. (Link)

Cornaby,A.; Simpson,M.; Vann,Rice R.; Dempsey,R.; Madras,P.; Jenkins,R.; Monaco,A.. Interleukin 2 levels and urine cytology distinguish between cyclosporine toxicity and rejection in renal and liver allograft recipients. Transplant Proc. 1988;20:827-830. (Link)